PIM
CLVS

Partner Investment Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Partner Investment Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-27,957
Closed -$821K – 122
2018
Q3 		$821K Buy
27,957
+1,093
+4% +$42.3K 0.63% 64
2018
Q2 		$1.22M Buy
+26,864
New +$1.31M 0.99% 38
2017
Q4 		– Sell
-4,053
Closed -$334K – 99
2017
Q3 		$334K Sell
4,053
-2,551
-39% -$202K 0.32% 70
2017
Q2 		$618K Sell
6,604
-15,233
-70% -$932K 0.83% 45
2017
Q1 		$1.39M Sell
21,837
-3,772
-15% -$229K 1.69% 21
2016
Q4 		$1.14M Buy
25,609
+7,630
+42% +$269K 1.51% 24
2016
Q3 		$648K Sell
17,979
-13,427
-43% -$288K 0.96% 42
2016
Q2 		$431K Sell
31,406
-539
-2% -$7.88K 0.71% 49
2016
Q1 		$613K Sell
31,945
-3,355
-10% -$71K 1% 32
2015
Q4 		$1.24M Sell
35,300
-11,979
-25% -$773K 2.03% 17
2015
Q3 		$4.35M Buy
47,279
+305
+0.6% +$26.4K 6.57% 1
2015
Q2 		$4.13M Buy
46,974
+6,176
+15% +$529K 5.8% 1
2015
Q1 		$3.03M Sell
40,798
-23,454
-37% -$1.66M 4.56% 1
2014
Q4 		$3.6M Buy
64,252
+27,454
+75% +$1.44M 1.47% 27
2014
Q3 		$1.67M Buy
36,798
+20,084
+120% +$839K 0.61% 33
2014
Q2 		$692K Sell
16,714
-65,836
-80% -$3.39M 0.14% 51
2014
Q1 		$5.72M Sell
82,550
-118,067
-59% -$8.67M 1.05% 34
2013
Q4 		$12.1M Buy
200,617
+47,611
+31% +$2.59M 2.74% 15
2013
Q3 		$9.3M Sell
153,006
-1,972
-1% -$140K 2.48% 16
2013
Q2 		$10.4M Buy
+154,978
New +$6.97M 2.35% 15

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

Partner Investment Management's CLVS Position: Q4 2018 in Review

Partner Investment Management sold out of Clovis Oncology, Inc. (CLVS) in Q4 2018, closing a stake of 27,957 shares — an estimated $821K sold.

Partner Investment Management first reported a position in CLVS in Q2 2013 and held it in 20 quarters. The position peaked at $12.1M in Q4 2013. 165 funds tracked by Wall St. Rank hold CLVS as of Q4 2018.

  • Partner Investment Management reported no remaining Clovis Oncology, Inc. position as of Q4 2018 after selling out during the quarter.
  • Partner Investment Management sold 27,957 Clovis Oncology, Inc. shares in Q4 2018, an estimated $821K.
  • Partner Investment Management first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 20 quarters.
  • Partner Investment Management's Clovis Oncology, Inc. position peaked at $12.1M in Q4 2013.
  • 165 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2018.

Based on Partner Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.